Bristol-Myers Squibb Co (BMY)
44.21
+0.27
(+0.61%)
USD |
NYSE |
May 01, 16:00
44.23
+0.02
(+0.05%)
Pre-Market: 20:00
Bristol-Myers Squibb Price: 44.21 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 43.97 | 44.47 | 43.73 | 44.21 | 13.24M |
Apr 30, 2024 | 44.40 | 44.76 | 43.93 | 43.94 | 17.72M |
Apr 29, 2024 | 45.09 | 45.38 | 44.53 | 44.64 | 16.43M |
Apr 26, 2024 | 44.68 | 45.37 | 44.34 | 44.85 | 21.28M |
Apr 25, 2024 | 47.39 | 47.50 | 44.37 | 44.70 | 45.07M |
Apr 24, 2024 | 49.00 | 49.04 | 48.55 | 48.86 | 16.06M |
Apr 23, 2024 | 49.16 | 49.47 | 48.96 | 48.99 | 9.153M |
Apr 22, 2024 | 49.00 | 49.56 | 48.87 | 49.14 | 7.930M |
Apr 19, 2024 | 48.21 | 49.05 | 48.12 | 48.93 | 10.30M |
Apr 18, 2024 | 47.93 | 48.40 | 47.62 | 48.30 | 10.92M |
Apr 17, 2024 | 48.44 | 48.55 | 47.70 | 47.84 | 11.76M |
Apr 16, 2024 | 48.45 | 48.60 | 48.24 | 48.26 | 11.93M |
Apr 15, 2024 | 48.36 | 49.10 | 48.12 | 48.51 | 11.94M |
Apr 12, 2024 | 49.04 | 49.09 | 48.26 | 48.28 | 12.46M |
Apr 11, 2024 | 50.46 | 50.58 | 49.11 | 49.12 | 11.78M |
Apr 10, 2024 | 51.04 | 51.28 | 50.28 | 50.29 | 11.49M |
Apr 09, 2024 | 51.13 | 51.68 | 51.07 | 51.60 | 9.488M |
Apr 08, 2024 | 51.28 | 51.30 | 50.86 | 51.10 | 12.26M |
Apr 05, 2024 | 51.19 | 51.45 | 50.77 | 51.32 | 9.096M |
Apr 04, 2024 | 51.94 | 52.08 | 51.20 | 51.40 | 10.99M |
Apr 03, 2024 | 52.75 | 52.87 | 52.10 | 52.18 | 10.43M |
Apr 02, 2024 | 53.10 | 53.35 | 52.53 | 52.74 | 10.23M |
Apr 01, 2024 | 54.17 | 54.23 | 52.96 | 52.99 | 9.520M |
Mar 28, 2024 | 53.39 | 54.48 | 53.39 | 54.23 | 14.35M |
Mar 27, 2024 | 53.00 | 53.69 | 52.85 | 53.25 | 13.08M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
42.77
Minimum
Jul 22 2019
81.13
Maximum
Dec 02 2022
61.97
Average
62.14
Median
Feb 25 2020
Price Benchmarks
Amgen Inc | 277.37 |
Biogen Inc | 216.13 |
Gilead Sciences Inc | 65.51 |
Karuna Therapeutics Inc (DELISTED) | 329.83 |
2seventy bio Inc | 4.60 |
Price Related Metrics
PS Ratio | 1.996 |
Price to Book Value | 5.435 |
Price to Free Cash Flow | 7.265 |
Earnings Yield | -7.01% |
Market Cap | 89.62B |
Operating PE Ratio | 12.49 |
Normalized PE Ratio | 57.24 |